Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sets New 1-Year Low – Should You Sell?

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) shares hit a new 52-week low during trading on Tuesday . The company traded as low as $4.86 and last traded at $4.88, with a volume of 2434151 shares. The stock had previously closed at $4.91.

Analysts Set New Price Targets

Separately, Bank of America upgraded Bayer Aktiengesellschaft from an “underperform” rating to a “neutral” rating in a research report on Friday, September 6th. Five equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Bayer Aktiengesellschaft Price Performance

The stock has a market capitalization of $19.14 billion, a PE ratio of -18.73 and a beta of 1.03. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.32 and a quick ratio of 0.81. The stock’s fifty day moving average is $5.80 and its 200-day moving average is $6.90.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.10). Bayer Aktiengesellschaft had a positive return on equity of 16.90% and a negative net margin of 2.02%. The firm had revenue of $10.96 billion during the quarter. As a group, equities analysts predict that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current fiscal year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.